Reviews Etidocaine HCl


No reviews yet.

Duranest Drug Description


Duranest
(etidocaine hcl) Injections


DURANEST INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT, AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST, AND POSSIBLY DEATH.

DRUG DESCRIPTION
Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The specific quantitative composition of each available solution is shown in Table 1.
Duranest Injections contain Etidocaine HCl, which is chemically designated as butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamine)-, monohydrochloride and Epinephrine which is (-)-3, 4-Dihydroxy-a-[(methylamino) methyl] benzyl alcohol. Chemical structure is as follows:
The PKa of etidocaine (7.74) is similar to that of lidocaine (7.86). However, etidocaine possesses a greater degree of lipid solubility and protein binding capacity than does lidocaine. Duranest Injections are sterile and, except for the 1.5% concentration, are available with or without epinephrine 1:200,000. Single dose containers of Duranest Injection without epinephrine may be reautoclaved it necessary.
See Table 1 for composition of available injections. Table1. Composition of Available Injections
Product Identification Formula Duranest (etidocaine HCl) Concentration % (mg/mL)  Epinephrine Dilution (as the bitartrate) (mg/mL) pH Sodium chloride (mg/mL) Single Dose Vials/Dental Cartridge Sodium metabisulfite (mg/mL)
Citric acid (mg/mL)

1.0
(10) None 4.0- 5.0  7.1 None   1.0 (1.0) 1 :200,000 (0.005 mg/mL)

3.0- 4.5 7.1 0.5 0.2 1.5 (1.5) 1 :200,000 (0.005 mg/mL) 3.0- 4.5 6.2 0.5 0.2
NOTE: pH of all solutions adjusted with sodium hydroxide and/ or hydrochloric acid. Duranest dental cartridges are only available as 1.5% solution with epinephrine 1:200,000. Filled under nitrogen. Last reviewed on RxList: 12/8/2004




Duranest Drug Description


Duranest
(etidocaine hcl) Injections


DURANEST INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT, AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST, AND POSSIBLY DEATH.

DRUG DESCRIPTION
Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The specific quantitative composition of each available solution is shown in Table 1.
Duranest Injections contain Etidocaine HCl, which is chemically designated as butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamine)-, monohydrochloride and Epinephrine which is (-)-3, 4-Dihydroxy-a-[(methylamino) methyl] benzyl alcohol. Chemical structure is as follows:
The PKa of etidocaine (7.74) is similar to that of lidocaine (7.86). However, etidocaine possesses a greater degree of lipid solubility and protein binding capacity than does lidocaine. Duranest Injections are sterile and, except for the 1.5% concentration, are available with or without epinephrine 1:200,000. Single dose containers of Duranest Injection without epinephrine may be reautoclaved it necessary.
See Table 1 for composition of available injections. Table1. Composition of Available Injections
Product Identification Formula Duranest (etidocaine HCl) Concentration % (mg/mL)  Epinephrine Dilution (as the bitartrate) (mg/mL) pH Sodium chloride (mg/mL) Single Dose Vials/Dental Cartridge Sodium metabisulfite (mg/mL)
Citric acid (mg/mL)

1.0
(10) None 4.0- 5.0  7.1 None   1.0 (1.0) 1 :200,000 (0.005 mg/mL)

3.0- 4.5 7.1 0.5 0.2 1.5 (1.5) 1 :200,000 (0.005 mg/mL) 3.0- 4.5 6.2 0.5 0.2
NOTE: pH of all solutions adjusted with sodium hydroxide and/ or hydrochloric acid. Duranest dental cartridges are only available as 1.5% solution with epinephrine 1:200,000. Filled under nitrogen. Last reviewed on RxList: 12/8/2004




Duranest Drug Description


Duranest
(etidocaine hcl) Injections


DURANEST INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT, AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST, AND POSSIBLY DEATH.

DRUG DESCRIPTION
Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The specific quantitative composition of each available solution is shown in Table 1.
Duranest Injections contain Etidocaine HCl, which is chemically designated as butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamine)-, monohydrochloride and Epinephrine which is (-)-3, 4-Dihydroxy-a-[(methylamino) methyl] benzyl alcohol. Chemical structure is as follows:
The PKa of etidocaine (7.74) is similar to that of lidocaine (7.86). However, etidocaine possesses a greater degree of lipid solubility and protein binding capacity than does lidocaine. Duranest Injections are sterile and, except for the 1.5% concentration, are available with or without epinephrine 1:200,000. Single dose containers of Duranest Injection without epinephrine may be reautoclaved it necessary.
See Table 1 for composition of available injections. Table1. Composition of Available Injections
Product Identification Formula Duranest (etidocaine HCl) Concentration % (mg/mL)  Epinephrine Dilution (as the bitartrate) (mg/mL) pH Sodium chloride (mg/mL) Single Dose Vials/Dental Cartridge Sodium metabisulfite (mg/mL)
Citric acid (mg/mL)

1.0
(10) None 4.0- 5.0  7.1 None   1.0 (1.0) 1 :200,000 (0.005 mg/mL)

3.0- 4.5 7.1 0.5 0.2 1.5 (1.5) 1 :200,000 (0.005 mg/mL) 3.0- 4.5 6.2 0.5 0.2
NOTE: pH of all solutions adjusted with sodium hydroxide and/ or hydrochloric acid. Duranest dental cartridges are only available as 1.5% solution with epinephrine 1:200,000. Filled under nitrogen. Last reviewed on RxList: 12/8/2004




Duranest Drug Description


Duranest
(etidocaine hcl) Injections


DURANEST INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT, AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST, AND POSSIBLY DEATH.

DRUG DESCRIPTION
Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The specific quantitative composition of each available solution is shown in Table 1.
Duranest Injections contain Etidocaine HCl, which is chemically designated as butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamine)-, monohydrochloride and Epinephrine which is (-)-3, 4-Dihydroxy-a-[(methylamino) methyl] benzyl alcohol. Chemical structure is as follows:
The PKa of etidocaine (7.74) is similar to that of lidocaine (7.86). However, etidocaine possesses a greater degree of lipid solubility and protein binding capacity than does lidocaine. Duranest Injections are sterile and, except for the 1.5% concentration, are available with or without epinephrine 1:200,000. Single dose containers of Duranest Injection without epinephrine may be reautoclaved it necessary.
See Table 1 for composition of available injections. Table1. Composition of Available Injections
Product Identification Formula Duranest (etidocaine HCl) Concentration % (mg/mL)  Epinephrine Dilution (as the bitartrate) (mg/mL) pH Sodium chloride (mg/mL) Single Dose Vials/Dental Cartridge Sodium metabisulfite (mg/mL)
Citric acid (mg/mL)

1.0
(10) None 4.0- 5.0  7.1 None   1.0 (1.0) 1 :200,000 (0.005 mg/mL)

3.0- 4.5 7.1 0.5 0.2 1.5 (1.5) 1 :200,000 (0.005 mg/mL) 3.0- 4.5 6.2 0.5 0.2
NOTE: pH of all solutions adjusted with sodium hydroxide and/ or hydrochloric acid. Duranest dental cartridges are only available as 1.5% solution with epinephrine 1:200,000. Filled under nitrogen. Last reviewed on RxList: 12/8/2004




Duranest Drug Description


Duranest
(etidocaine hcl) Injections


DURANEST INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT, AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST, AND POSSIBLY DEATH.

DRUG DESCRIPTION
Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The specific quantitative composition of each available solution is shown in Table 1.
Duranest Injections contain Etidocaine HCl, which is chemically designated as butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamine)-, monohydrochloride and Epinephrine which is (-)-3, 4-Dihydroxy-a-[(methylamino) methyl] benzyl alcohol. Chemical structure is as follows:
The PKa of etidocaine (7.74) is similar to that of lidocaine (7.86). However, etidocaine possesses a greater degree of lipid solubility and protein binding capacity than does lidocaine. Duranest Injections are sterile and, except for the 1.5% concentration, are available with or without epinephrine 1:200,000. Single dose containers of Duranest Injection without epinephrine may be reautoclaved it necessary.
See Table 1 for composition of available injections. Table1. Composition of Available Injections
Product Identification Formula Duranest (etidocaine HCl) Concentration % (mg/mL)  Epinephrine Dilution (as the bitartrate) (mg/mL) pH Sodium chloride (mg/mL) Single Dose Vials/Dental Cartridge Sodium metabisulfite (mg/mL)
Citric acid (mg/mL)

1.0
(10) None 4.0- 5.0  7.1 None   1.0 (1.0) 1 :200,000 (0.005 mg/mL)

3.0- 4.5 7.1 0.5 0.2 1.5 (1.5) 1 :200,000 (0.005 mg/mL) 3.0- 4.5 6.2 0.5 0.2
NOTE: pH of all solutions adjusted with sodium hydroxide and/ or hydrochloric acid. Duranest dental cartridges are only available as 1.5% solution with epinephrine 1:200,000. Filled under nitrogen. Last reviewed on RxList: 12/8/2004





Other reviews about Etidocaine HCl on wordpress

Anesthesia Memos
  by mwhauser
AAA: ENDOVASCULAR The endovascular AAA repair is typically performed under high lumbar or low thoracic epidural anesthesia with MAC. LIDOCAINE is often a good choice as these patients […]


Cocaine and Crack Cocaine
  by ZoSoTRUTHTALK
Cocaine For other uses, see Cocaine (disambiguation). Cocaine Systematic (IUPAC) name methyl (1R,2R,3S,5S)-3- (benzoyloxy)-8-methyl-8-azabicyclo[3.2.1] octane-2-carboxylate […]



Other reviews about Etidocaine HCl on web:

Learn about the prescription medication Duranest (Etidocaine HCl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Duranest (Etidocaine HCl) Drug Information: Uses, Side Effects ...


Sota Omoigui's Anesthesia Drug Handbook 3rd Edition: : Etidocaine Hcl MedicineHouse.com


ethylene /ethテδづつキyテδづつキlene/ (ethテδづつエテδテつュ-lテδテつ渡) a colorless flammable gas, CH2dbondCH2, with a slightly sweet odor and taste; formerly used as an inhalation anesthetic. etidocaine HCl - definition of etidocaine HCl in the Medical ...


DESCRIPTION Duranest (Etidocaine HCl) Injections are sterile aqueous solutions that contain a local anesthetic agent and are administered parenterally by injection. See ... Etidocaine HCl


etidocaine HCl (local) n trade names: Duranest, Duranest MPF; drug class: amide, local anesthetic; action: inhibits ion fluxes across membranes, etidocaine HCl (local): Definition from Answers.com


The effectiveness of 1.5% etidocaine HCl with epinephrine 1:200,000 and 2% lidocaine HCl with epinephrine 1:100,000 in oral surgery: a clinical comparison The effectiveness of 1.5% etidocaine HCl with epinephrine 1 ...


ethylene (テδテつ付h`テδ嘉つ冤テδテつ渡') or ethene (テδテつ付h`テδテつ渡), H 2 C=CH 2, a gaseous unsaturated hydrocarbon. It is the simplest alkene alkene, any of a group of aliphatic hydrocarbons whose molecules ... etidocaine HCl definition of etidocaine HCl in the Free Online ...


ethテδづつキylテδづつキene (th-l n) n. A colorless flammable gas, C 2 H 4, derived from natural gas and petroleum and used as a source of many organic compounds, in welding and cutting metals, to ... etidocaine HCl - definition of etidocaine HCl by the Free Online ...


Etidocaine HCl Sites. Duranest Online, Description, Chemistry, Ingredients - Full prescribing information from RxList. http://www.rxlist.com/cgi/generic3/etidocaine.htm Etidocaine HCl | healthpolicycoach.org


Title: Take Etidocaine HCl in 24medicines.net Description: SIDE EFFECTS . Buying Prochlorperazine Legally. Purchase Prochlorperazine On- Line. ... buy online order cheap ... take-etidocaine-hcl.24medicines.net





Featured Reviews

Reviews Calcipotriene and Betamethasone Dipropionate

Taclonex Drug Description TACLONEX® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) OINTMENT FOR TOPICAL USE ONLY. Not for Ophthalmic, Oral or Intravaginal Use. DRUG DESCRIPTION What are the possible side effects...
Read More  |  Review This
Reviews Vivelle-Dot

Vivelle-Dot Drug Description Vivelle-Dot® (estradiol transdermal system) Continuous delivery for twice-weekly application ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens...
Read More  |  Review This
Reviews Neosporin Ophthalmic Ointment

Neosporin Ophthalmic Ointment Drug Description NEOSPORIN® Ophthalmic Ointment Sterile (neomycin and polymyxin B sulfates and bacitracin zinc) Ophthalmic Ointment, USP) DRUG DESCRIPTION NEOSPORIN Ophthalmic Ointment (neomycin and polymyxin...
Read More  |  Review This
Reviews Sodium Sulfacetamide Lotion

Klaron Drug Description KLARON® (sodium sulfacetamide lotion) Lotion, 10% DRUG DESCRIPTION What are the possible side effects of sodium sulfacetamide topical (Klaron, Sebizon)? Serious side effects are not likely to occur with...
Read More  |  Review This
Reviews Clofarabine

Clolar Drug Description Clolar® (clofarabine) Injection MUST BE DILUTED PRIOR TO IV USE DRUG DESCRIPTION What are the possible side effects of clofarabine (Clolar)? If you experience any of the following serious side effects,...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....